📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease. (2022)

First Author: Wong C

Attributed to: Cellular and molecular insights into neurodegeneration mediated by the C9orf72 gene mutation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2022-064173

PubMed Identifier: 35798516

Publication URI: http://europepmc.org/abstract/MED/35798516

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 7

ISSN: 2044-6055